Finnian Raymond McCausland, M.B.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Dialysis | 12 | 2023 | 1783 | 1.950 |
Why?
|
Kidney Failure, Chronic | 8 | 2023 | 2535 | 1.200 |
Why?
|
Hematinics | 3 | 2023 | 280 | 1.180 |
Why?
|
Dialysis Solutions | 3 | 2023 | 38 | 1.040 |
Why?
|
Hypotension | 4 | 2023 | 884 | 0.880 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2023 | 113 | 0.870 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2023 | 2200 | 0.570 |
Why?
|
Sodium | 2 | 2011 | 1622 | 0.550 |
Why?
|
Biphenyl Compounds | 7 | 2023 | 913 | 0.480 |
Why?
|
Hypertension | 4 | 2023 | 8479 | 0.470 |
Why?
|
Angiotensin Receptor Antagonists | 8 | 2023 | 923 | 0.470 |
Why?
|
Heart Failure | 9 | 2023 | 10895 | 0.460 |
Why?
|
Marital Status | 1 | 2014 | 437 | 0.430 |
Why?
|
Blood Pressure | 4 | 2023 | 8551 | 0.420 |
Why?
|
Mannitol | 1 | 2012 | 181 | 0.400 |
Why?
|
Kidney Diseases | 2 | 2012 | 2148 | 0.370 |
Why?
|
Diet, Sodium-Restricted | 1 | 2012 | 287 | 0.360 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 15160 | 0.340 |
Why?
|
Anemia | 1 | 2018 | 1503 | 0.340 |
Why?
|
Glomerulonephritis | 1 | 2011 | 372 | 0.340 |
Why?
|
Sodium, Dietary | 1 | 2012 | 418 | 0.320 |
Why?
|
Acute Kidney Injury | 2 | 2021 | 1968 | 0.310 |
Why?
|
Tetrazoles | 5 | 2023 | 835 | 0.290 |
Why?
|
Lyme Disease | 1 | 2011 | 621 | 0.260 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3778 | 0.250 |
Why?
|
Kidney Transplantation | 2 | 2023 | 4251 | 0.210 |
Why?
|
Drug Combinations | 6 | 2023 | 1958 | 0.210 |
Why?
|
Hyperkalemia | 1 | 2023 | 218 | 0.200 |
Why?
|
Weight Gain | 1 | 2011 | 2293 | 0.200 |
Why?
|
Urea | 1 | 2023 | 450 | 0.200 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2008 | 277 | 0.200 |
Why?
|
Hypocalcemia | 1 | 2021 | 191 | 0.180 |
Why?
|
Erythropoietin | 1 | 2023 | 726 | 0.160 |
Why?
|
Hemodiafiltration | 1 | 2016 | 20 | 0.140 |
Why?
|
Atrial Appendage | 1 | 2019 | 283 | 0.130 |
Why?
|
Male | 17 | 2023 | 350115 | 0.130 |
Why?
|
Smoking | 1 | 2012 | 8987 | 0.130 |
Why?
|
Stroke Volume | 6 | 2023 | 5006 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2022 | 1516 | 0.130 |
Why?
|
Insurance Claim Review | 1 | 2019 | 720 | 0.120 |
Why?
|
Uric Acid | 1 | 2020 | 766 | 0.120 |
Why?
|
Urine | 1 | 2016 | 370 | 0.120 |
Why?
|
Osmolar Concentration | 1 | 2015 | 683 | 0.120 |
Why?
|
Prospective Studies | 6 | 2023 | 53290 | 0.120 |
Why?
|
Female | 16 | 2023 | 380193 | 0.120 |
Why?
|
Middle Aged | 12 | 2023 | 213390 | 0.120 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5749 | 0.120 |
Why?
|
Double-Blind Method | 2 | 2018 | 12025 | 0.110 |
Why?
|
Aged | 11 | 2022 | 163288 | 0.110 |
Why?
|
Humans | 29 | 2023 | 744366 | 0.110 |
Why?
|
Hypertonic Solutions | 1 | 2012 | 93 | 0.110 |
Why?
|
Diuretics, Osmotic | 1 | 2012 | 37 | 0.110 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11718 | 0.110 |
Why?
|
Kidney | 3 | 2023 | 7184 | 0.100 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2011 | 66 | 0.100 |
Why?
|
Delayed Graft Function | 1 | 2011 | 48 | 0.100 |
Why?
|
Metabolic Clearance Rate | 1 | 2011 | 380 | 0.100 |
Why?
|
Cause of Death | 1 | 2021 | 3582 | 0.100 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 128 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 11726 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 354 | 0.090 |
Why?
|
Blood Volume | 1 | 2012 | 565 | 0.090 |
Why?
|
Hematuria | 1 | 2011 | 235 | 0.090 |
Why?
|
Antigen-Antibody Complex | 1 | 2011 | 517 | 0.090 |
Why?
|
Adult | 7 | 2023 | 214052 | 0.080 |
Why?
|
Stroke | 2 | 2023 | 9981 | 0.080 |
Why?
|
Hyponatremia | 1 | 2011 | 298 | 0.080 |
Why?
|
Potassium | 1 | 2012 | 1336 | 0.080 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 948 | 0.080 |
Why?
|
Postoperative Hemorrhage | 1 | 2011 | 412 | 0.080 |
Why?
|
Treatment Outcome | 6 | 2023 | 63107 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1768 | 0.070 |
Why?
|
Dietary Proteins | 1 | 2012 | 963 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.070 |
Why?
|
Patient Readmission | 1 | 2019 | 3116 | 0.060 |
Why?
|
Diabetic Nephropathies | 1 | 2012 | 984 | 0.060 |
Why?
|
Time Factors | 3 | 2018 | 40075 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3537 | 0.060 |
Why?
|
Energy Intake | 1 | 2012 | 2148 | 0.060 |
Why?
|
Blood Vessel Prosthesis | 1 | 2008 | 934 | 0.060 |
Why?
|
Nutritional Status | 1 | 2012 | 1609 | 0.060 |
Why?
|
Ramipril | 1 | 2023 | 95 | 0.060 |
Why?
|
Risk Assessment | 2 | 2016 | 23336 | 0.050 |
Why?
|
Vascular Surgical Procedures | 2 | 2008 | 1476 | 0.050 |
Why?
|
Hemodynamics | 1 | 2012 | 4196 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5953 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5035 | 0.050 |
Why?
|
Erythropoiesis | 1 | 2023 | 706 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 257 | 0.040 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3666 | 0.040 |
Why?
|
Cohort Studies | 2 | 2012 | 40559 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10252 | 0.040 |
Why?
|
Hospitalization | 2 | 2022 | 10259 | 0.040 |
Why?
|
Risk Factors | 3 | 2023 | 72296 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12244 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2022 | 758 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12356 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1532 | 0.040 |
Why?
|
Aftercare | 1 | 2022 | 870 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3531 | 0.030 |
Why?
|
Prevalence | 1 | 2012 | 15221 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39052 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21696 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7182 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2023 | 3799 | 0.030 |
Why?
|
Prognosis | 1 | 2011 | 29060 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3318 | 0.020 |
Why?
|
United States | 2 | 2019 | 69872 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2616 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 20952 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2019 | 5316 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7914 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9955 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2008 | 2124 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 77460 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2008 | 15297 | 0.000 |
Why?
|